Using cell phones to diagnose breast tumors
Point-of-care cellular and molecular pathology of breast tumors on a cell phone
This study is working on a new way to use cell phone technology to quickly and accurately diagnose breast cancer, especially for people in areas where regular medical services are hard to get, so that patients can get the help they need sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10830317 on NIH RePORTER |
What this research studies
This research focuses on developing a portable and accessible method for diagnosing breast cancer using cell phone technology. It aims to provide timely and accurate pathological confirmation of breast tumors, especially in low-resource settings where traditional pathology services are limited. By analyzing cellular and molecular characteristics of breast tumors through mobile devices, the research seeks to improve patient access to essential diagnostic services and facilitate early treatment. The approach includes identifying abnormal cell morphologies and tumor biomarkers that are crucial for determining the appropriate treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include women diagnosed with breast cancer, particularly those living in low-resource settings.
Not a fit: Patients who have already received comprehensive pathology services and treatment for breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early breast cancer diagnosis and treatment access for patients in underserved areas.
How similar studies have performed: Other research has shown promise in using mobile technology for health diagnostics, indicating potential success for this novel approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Chilkoti, Ashutosh — Duke University
- Study coordinator: Chilkoti, Ashutosh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.